Deals
Cypress Gains as Ramius Boosts Bid to $5.50 a Share
This article is for subscribers only.
Cypress Bioscience Inc. gained the most in almost five months in Nasdaq trading after Ramius LLC increased its offer to buy the company by 29 percent, to $5.50 a share.
Shares of Cypress, based in San Diego, surged 21 percent, or 87 cents, to $4.93 at 4 p.m. New York time for the biggest gain since July 19. The stock has lost 15 percent this year.